Exact Mass: 549.2369
Exact Mass Matches: 549.2369
Found 500 metabolites which its exact mass value is equals to given mass value 549.2369
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fluphenazine enanthate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Jadomycin B
A jadomycin that is jadomycin A in which the phenolic hydroxy group at position 12 has been converted to the corresponding 2,6-dideoxy-alpha-L-ribo-hexopyranoside, isolated from Streptomyces venezuelae. It exists as a diastereoisomeric mixture consisting of both 3aS and 3aR isomers.
Tripeptide
3-Hydroxy-8b-ethyl ether-rocaglatic acid dimethylamide
(+)-(13R,19S)-1beta,11alpha-diacetoxy-2alpha-benzoyloxy-13,19-dihydroxyhetisan|(+)-(13S,19R)-1beta,11alpha-diacetoxy-2alpha-benzoyloxy-13,19-dihydroxyhetisan
Ala His His Trp
Ala His Trp His
Ala Trp His His
Cys Glu Ile Trp
Cys Glu Leu Trp
Cys Glu Trp Ile
Cys Glu Trp Leu
Cys His Lys Tyr
Cys His Gln Tyr
Cys His Tyr Lys
Cys His Tyr Gln
Cys Ile Glu Trp
Cys Ile Trp Glu
Cys Lys His Tyr
Cys Lys Asn Trp
Cys Lys Trp Asn
Cys Lys Tyr His
Cys Leu Glu Trp
Cys Leu Trp Glu
Cys Asn Lys Trp
Cys Asn Gln Trp
Cys Asn Trp Lys
Cys Asn Trp Gln
Cys Gln His Tyr
Cys Gln Asn Trp
Cys Gln Trp Asn
Cys Gln Tyr His
Cys Trp Glu Ile
Cys Trp Glu Leu
Cys Trp Ile Glu
Cys Trp Lys Asn
Cys Trp Leu Glu
Cys Trp Asn Lys
Cys Trp Asn Gln
Cys Trp Gln Asn
Cys Tyr His Lys
Cys Tyr His Gln
Cys Tyr Lys His
Cys Tyr Gln His
Asp Glu Met Arg
Asp Glu Arg Met
Asp Glu Thr Trp
Asp Glu Trp Thr
Asp Met Glu Arg
Asp Met Arg Glu
Asp Met Val Trp
Asp Met Trp Val
Asp Pro Arg Tyr
Asp Pro Tyr Arg
Asp Arg Glu Met
Asp Arg Met Glu
Asp Arg Pro Tyr
Asp Arg Tyr Pro
Asp Thr Glu Trp
Asp Thr Trp Glu
Asp Val Met Trp
Asp Val Trp Met
Asp Trp Glu Thr
Asp Trp Met Val
Asp Trp Thr Glu
Asp Trp Val Met
Asp Tyr Pro Arg
Asp Tyr Arg Pro
Glu Cys Ile Trp
Glu Cys Leu Trp
Glu Cys Trp Ile
Glu Cys Trp Leu
Glu Asp Met Arg
Glu Asp Arg Met
Glu Asp Thr Trp
Glu Asp Trp Thr
Glu Glu Ser Trp
Glu Glu Trp Ser
Glu His His Lys
Glu His His Gln
Glu His Lys His
Glu His Gln His
Glu Ile Cys Trp
Glu Ile Trp Cys
Glu Lys His His
Glu Leu Cys Trp
Glu Leu Trp Cys
Glu Met Asp Arg
Glu Met Arg Asp
Glu Gln His His
Glu Arg Asp Met
Glu Arg Met Asp
Glu Ser Glu Trp
Glu Ser Trp Glu
Glu Thr Asp Trp
Glu Thr Trp Asp
Glu Trp Cys Ile
Glu Trp Cys Leu
Glu Trp Asp Thr
Glu Trp Glu Ser
Glu Trp Ile Cys
Glu Trp Leu Cys
Glu Trp Ser Glu
Glu Trp Thr Asp
Phe Met Pro Arg
Phe Met Arg Pro
Phe Asn Asn Arg
Phe Asn Arg Asn
Phe Pro Met Arg
Phe Pro Arg Met
Phe Pro Thr Trp
Phe Pro Trp Thr
Phe Gln Gln Gln
Phe Arg Met Pro
Phe Arg Asn Asn
Phe Arg Pro Met
Phe Thr Pro Trp
Phe Thr Trp Pro
Phe Trp Pro Thr
Phe Trp Thr Pro
His Ala His Trp
His Ala Trp His
His Cys Lys Tyr
His Cys Gln Tyr
His Cys Tyr Lys
His Cys Tyr Gln
His Glu His Lys
His Glu His Gln
His Glu Lys His
His Glu Gln His
His His Ala Trp
His His Glu Lys
His His Glu Gln
His His Lys Glu
His His Gln Glu
His His Trp Ala
His Lys Cys Tyr
His Lys Glu His
His Lys His Glu
His Lys Tyr Cys
His Gln Cys Tyr
His Gln Glu His
His Gln His Glu
His Gln Tyr Cys
His Trp Ala His
His Trp His Ala
His Tyr Cys Lys
His Tyr Cys Gln
His Tyr Lys Cys
His Tyr Gln Cys
Ile Cys Glu Trp
Ile Cys Trp Glu
Ile Glu Cys Trp
Ile Glu Trp Cys
Ile Met Thr Trp
Ile Met Trp Thr
Ile Thr Met Trp
Ile Thr Trp Met
Ile Trp Cys Glu
Ile Trp Glu Cys
Ile Trp Met Thr
Ile Trp Thr Met
Lys Cys His Tyr
Lys Cys Asn Trp
Lys Cys Trp Asn
Lys Cys Tyr His
Lys Glu His His
Lys His Cys Tyr
Lys His Glu His
Lys His His Glu
Lys His Tyr Cys
Lys Asn Cys Trp
Lys Asn Trp Cys
Lys Trp Cys Asn
Lys Trp Asn Cys
Lys Tyr Cys His
Lys Tyr His Cys
Leu Cys Glu Trp
Leu Cys Trp Glu
Leu Glu Cys Trp
Leu Glu Trp Cys
Leu Met Thr Trp
Leu Met Trp Thr
Leu Thr Met Trp
Leu Thr Trp Met
Leu Trp Cys Glu
Leu Trp Glu Cys
Leu Trp Met Thr
Leu Trp Thr Met
Met Asp Glu Arg
Met Asp Arg Glu
Met Asp Val Trp
Met Asp Trp Val
Met Glu Asp Arg
Met Glu Arg Asp
Met Phe Pro Arg
Met Phe Arg Pro
Met Ile Thr Trp
Met Ile Trp Thr
Met Leu Thr Trp
Met Leu Trp Thr
Met Pro Phe Arg
Met Pro Arg Phe
Met Arg Asp Glu
Met Arg Glu Asp
Met Arg Phe Pro
Met Arg Pro Phe
Met Thr Ile Trp
Met Thr Leu Trp
Met Thr Trp Ile
Met Thr Trp Leu
Met Val Asp Trp
Met Val Trp Asp
Met Trp Asp Val
Met Trp Ile Thr
Met Trp Leu Thr
Met Trp Thr Ile
Met Trp Thr Leu
Met Trp Val Asp
Asn Cys Lys Trp
Asn Cys Gln Trp
Asn Cys Trp Lys
Asn Cys Trp Gln
Asn Phe Asn Arg
Asn Phe Arg Asn
Asn Lys Cys Trp
Asn Lys Trp Cys
Asn Asn Phe Arg
Asn Asn Arg Phe
Asn Gln Cys Trp
Asn Gln Trp Cys
Asn Arg Phe Asn
Asn Arg Asn Phe
Asn Trp Cys Lys
Asn Trp Cys Gln
Asn Trp Lys Cys
Asn Trp Gln Cys
Pro Asp Arg Tyr
Pro Asp Tyr Arg
Pro Phe Met Arg
Pro Phe Arg Met
Pro Phe Thr Trp
Pro Phe Trp Thr
Pro Met Phe Arg
Pro Met Arg Phe
Pro Arg Asp Tyr
Pro Arg Phe Met
Pro Arg Met Phe
Pro Arg Tyr Asp
Pro Thr Phe Trp
Pro Thr Trp Phe
Pro Trp Phe Thr
Pro Trp Thr Phe
Pro Tyr Asp Arg
Pro Tyr Arg Asp
Gln Cys His Tyr
Gln Cys Asn Trp
Gln Cys Trp Asn
Gln Cys Tyr His
Gln Glu His His
Gln Phe Gln Gln
Gln His Cys Tyr
Gln His Glu His
Gln His His Glu
Gln His Tyr Cys
Gln Asn Cys Trp
Gln Asn Trp Cys
Gln Gln Phe Gln
Gln Gln Gln Phe
Gln Trp Cys Asn
Gln Trp Asn Cys
Gln Tyr Cys His
Gln Tyr His Cys
Arg Asp Glu Met
Arg Asp Met Glu
Arg Asp Pro Tyr
Arg Asp Tyr Pro
Arg Glu Asp Met
Arg Glu Met Asp
Arg Phe Met Pro
Arg Phe Asn Asn
Arg Phe Pro Met
Arg Met Asp Glu
Arg Met Glu Asp
Arg Met Phe Pro
Arg Met Pro Phe
Arg Asn Phe Asn
Arg Asn Asn Phe
Arg Pro Asp Tyr
Arg Pro Phe Met
Arg Pro Met Phe
Arg Pro Tyr Asp
Arg Tyr Asp Pro
Arg Tyr Pro Asp
Ser Glu Glu Trp
Ser Glu Trp Glu
Ser Trp Glu Glu
Thr Asp Glu Trp
Thr Asp Trp Glu
Thr Glu Asp Trp
Thr Glu Trp Asp
Thr Phe Pro Trp
Thr Phe Trp Pro
Thr Ile Met Trp
Thr Ile Trp Met
Thr Leu Met Trp
Thr Leu Trp Met
Thr Met Ile Trp
Thr Met Leu Trp
Thr Met Trp Ile
Thr Met Trp Leu
Thr Pro Phe Trp
Thr Pro Trp Phe
Thr Trp Asp Glu
Thr Trp Glu Asp
Thr Trp Phe Pro
Thr Trp Ile Met
Thr Trp Leu Met
Thr Trp Met Ile
Thr Trp Met Leu
Thr Trp Pro Phe
Val Asp Met Trp
Val Asp Trp Met
Val Met Asp Trp
Val Met Trp Asp
Val Trp Asp Met
Val Trp Met Asp
Trp Ala His His
Trp Cys Glu Ile
Trp Cys Glu Leu
Trp Cys Ile Glu
Trp Cys Lys Asn
Trp Cys Leu Glu
Trp Cys Asn Lys
Trp Cys Asn Gln
Trp Cys Gln Asn
Trp Asp Glu Thr
Trp Asp Met Val
Trp Asp Thr Glu
Trp Asp Val Met
Trp Glu Cys Ile
Trp Glu Cys Leu
Trp Glu Asp Thr
Trp Glu Glu Ser
Trp Glu Ile Cys
Trp Glu Leu Cys
Trp Glu Ser Glu
Trp Glu Thr Asp
Trp Phe Pro Thr
Trp Phe Thr Pro
Trp His Ala His
Trp His His Ala
Trp Ile Cys Glu
Trp Ile Glu Cys
Trp Ile Met Thr
Trp Ile Thr Met
Trp Lys Cys Asn
Trp Lys Asn Cys
Trp Leu Cys Glu
Trp Leu Glu Cys
Trp Leu Met Thr
Trp Leu Thr Met
Trp Met Asp Val
Trp Met Ile Thr
Trp Met Leu Thr
Trp Met Thr Ile
Trp Met Thr Leu
Trp Met Val Asp
Trp Asn Cys Lys
Trp Asn Cys Gln
Trp Asn Lys Cys
Trp Asn Gln Cys
Trp Pro Phe Thr
Trp Pro Thr Phe
Trp Gln Cys Asn
Trp Gln Asn Cys
Trp Ser Glu Glu
Trp Thr Asp Glu
Trp Thr Glu Asp
Trp Thr Phe Pro
Trp Thr Ile Met
Trp Thr Leu Met
Trp Thr Met Ile
Trp Thr Met Leu
Trp Thr Pro Phe
Trp Val Asp Met
Trp Val Met Asp
Tyr Cys His Lys
Tyr Cys His Gln
Tyr Cys Lys His
Tyr Cys Gln His
Tyr Asp Pro Arg
Tyr Asp Arg Pro
Tyr His Cys Lys
Tyr His Cys Gln
Tyr His Lys Cys
Tyr His Gln Cys
Tyr Lys Cys His
Tyr Lys His Cys
Tyr Pro Asp Arg
Tyr Pro Arg Asp
Tyr Gln Cys His
Tyr Gln His Cys
Tyr Arg Asp Pro
Tyr Arg Pro Asp
ETHYL 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINYL]-1
disodium (Z)-[2-[(1-oxooctadec-9-enyl)amino]ethyl] 2-sulphonatosuccinate
DI-tert-butyl (2S,3S,4R)-4-((3-(1,1-difluoroallyl)-7-methoxyquinoxalin-2-yl)oxy)-3-ethylpyrrolidine-1,2-dicarboxylate
(2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid
Dibekacin sulfate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid
2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl
(2S)-2-[[[4-[(4-chloroanilino)-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]-6-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]hexanoic acid tert-butyl ester
2-azaniumylethyl (2R)-2-{[(5Z,11alpha,13E,15S)-11,15-dihydroxy-1,9-dioxoprosta-5,13-dien-1-yl]oxy}-3-hydroxypropyl phosphate
2-azaniumylethyl (2R)-3-hydroxy-2-{[(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoyl]oxy}propyl phosphate
(2R)-2-[(4S,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5S)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
[(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(4-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(1-piperidinyl)methanone
[(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(2-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-piperidin-1-ylmethanone
(2R)-2-[(4S,5S)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl(3-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
[(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(4-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(1-piperidinyl)methanone
[(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(2-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridin-6-yl]-(1-piperidinyl)methanone
(2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoate
3-[[3-acetyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
7-Methyl-1-phenyl-4-trimethylsilyl-7-azobicyclo(2,2,1)heptane-N,N-diphenyl-2,3,5,6-tetracarboxodiimido
fluphenazine enanthate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine zwitterion
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
2-[(9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine zwitterion
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-[(9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
2-[(9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (9S,11R)-epidioxy-(15S)-hydroxy-(5Z,13E)-prostadienoyl.
ERK1/2 inhibitor 1
ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1/2 inhibitor, showing 60\% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively[1].
[(1r,2s,10r,12r,13s)-12-cyano-7,18-dimethoxy-6,17,21-trimethyl-5,8,16,19-tetraoxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl propanoate
2,3-dihydroxy-n-(4-hydroxybutyl)-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
(2s,3r,4r,5s,6r)-2,3-dihydroxy-n-(4-hydroxybutyl)-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
asperulosidic acid_qt
{"Ingredient_id": "HBIN017143","Ingredient_name": "asperulosidic acid_qt","Alias": "NA","Ingredient_formula": "C32H39NO7","Ingredient_Smile": "NA","Ingredient_weight": "549.65","OB_score": "55.55587601","CAS_id": "25374-68-9","SymMap_id": "SMIT11614","TCMID_id": "NA","TCMSP_id": "MOL010593","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}